The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Geographic and Genomic Distribution of SARS-CoV-2 Mutations
Open accessAbstract
The novel respiratory disease COVID-19 has reached the status of worldwide pandemic and large efforts are currently being undertaken in molecularly characterizing the virus causing it, SARS-CoV-2. The genomic variability of SARS-CoV-2 specimens scattered across the globe can underly geographically specific etiological effects. In the present study, we gather the 48,635 SARS-CoV-2 complete genomes currently available thanks to the collection endeavor of the GISAID consortium and thousands of contributing laboratories. We analyzed and annotated all SARS-CoV-2 mutations compared with the reference Wuhan genome NC_045512.2, observing an average of 7.23 mutations per sample. Our analysis shows the prevalence of single nucleotide transitions as the major mutational type across the world. There exist at least three clades characterized by geographic and genomic specificity. In particular, clade G, prevalent in Europe, carries a D614G mutation in the Spike protein, which is responsible for the initial interaction of the virus with the host human cell. Our analysis may facilitate custom-designed antiviral strategies based on the molecular specificities of SARS-CoV-2 in different patients and geographical locations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K.-Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.045 · Cited by 2,892 · cited 6×
“This mutation causes a D614G (aspartate to glycine in protein position 614) aa-change of the Spike (S) protein, which is responsible for the initial entry of the virus in the cell via the ACE2 human receptor (Guzzi et al., 2020).”
BackgroundInfluentialGruber, A. R., Lorenz, R., Bernhart, S. H., Neubock, R., & Hofacker, I. L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn188 · Cited by 2,688
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
SARS-CoV-2 Vaccines: Status Report
Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120
Fast algorithms for large-scale genome alignment and comparison
Delcher, A. L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.11.2478 · Cited by 1,036
Phylogenetic network analysis of SARS-CoV-2 genomes
Forster, P., Forster, L., Renfrew, C., & Forster, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004999117 · Cited by 1,020
Demographic science aids in understanding the spread and fatality rates of COVID-19
Dowd, J. B., Andriano, L., Brazel, D. M., Rotondi, V., Block, P., Ding, X., Liu, Y., & Mills, M. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004911117 · Cited by 905
Shen, Z., Xiao, Y., Kang, L., Ma, W., Shi, L., Zhang, L., Zhou, Z., Yang, J., Zhong, J., Yang, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa203 · Cited by 513 · cited 1×
“This data avalanche will result in an unprecedently rapid effort to analyze data to understand genome diversity (Andersen et al., 2020; Shen et al., 2020), to hypothesize suitable targets for drug repositioning (Wu et al., 2020; Zhou et al., 2020) and to develop prevention strategies (Zhao and…”
BackgroundGenomic variance of the 2019‐nCoV coronavirus
Ceraolo, C., & Giorgi, F. M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25700 · Cited by 397
Self-citationModeling the epidemic dynamics and control of COVID‐19 outbreak in China
Zhao, S., & Chen, H. (2020) · Quantitative Biology · doi:10.1007/s40484-020-0199-0 · Cited by 368
Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2
Di Giorgio, S., Martignano, F., Torcia, M. G., Mattiuz, G., & Conticello, S. G. (2020) · Science Advances · doi:10.1126/sciadv.abb5813 · Cited by 355
SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
Becerra‐Flores, M., & Cardozo, T. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13525 · Cited by 295
Master Regulator Analysis of the SARS-CoV-2/Human Interactome
Guzzi, P. H., Mercatelli, D., Ceraolo, C., & Giorgi, F. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040982 · Cited by 193
Self-citationA dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology
Rambaut, A., Holmes, E. C., Hill, V., O’Toole, Á., McCrone, J., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.17.046086 · Cited by 158
Hufsky, F., Lamkiewicz, K., Almeida, A., Aouacheria, A., Arighi, C. N., Bateman, A. G., Baumbach, J., Beerenwinkel, N., Brandt, C., Cacciabue, M., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa232 · Cited by 143
Distinct viral clades of SARS‐CoV‐2: Implications for modeling of viral spread
Brufsky, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25902 · Cited by 131
APOBEC3-mediated restriction of RNA virus replication
Milewska, A., Kindler, E., V’kovski, P., Żegleń, S., Ochman, M., Thiel, V., Rajfur, Z., & Pyrć, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-24448-2 · Cited by 104
Coronapp : A web application to annotate and monitor SARS‐CoV‐2 mutations
Mercatelli, D., Triboli, L., Fornasari, E., Ray, F., & Giorgi, F. M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26678 · Cited by 91
Self-citationEpidemiological data analysis of viral quasispecies in the next-generation sequencing era
Knyazev, S., Hughes, L., Skums, P., & Zelikovsky, A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa101 · Cited by 61
Hufsky, F., Lamkiewicz, K., Almeida, A., Aouacheria, A., Arighi, C. N., Bateman, A. G., Baumbach, J., Beerenwinkel, N., Brandt, C., Cacciabue, M., et al. (2020) · Preprints.org · doi:10.20944/preprints202005.0376.v1 · Cited by 18
Cited by
Genomic evidence for reinfection with SARS-CoV-2: a case study
Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N., Gorzalski, A., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 754
Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30773-8 · Cited by 633
COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence
Naveca, F. G., Nascimento, V., de Souza, V. C., Corado, A. D. L., Nascimento, F., Silva, G., Costa, Á., Duarte, D., Pessoa, K., Mejía, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01378-7 · Cited by 462
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Westendorf, K., Žentelis, S., Wang, L., Foster, D., Vaillancourt, P., Wiggin, M., Lovett, E., van der Lee, R., Hendle, J., Pustilnik, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110812 · Cited by 414
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324
Metadata
- Authors
- Mercatelli, D., & Giorgi, F. M.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-22
- Volume
- 11
- Pages
- 1800-1800
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W3022687324
- Cited by
- 589
- References
- 29
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.